MAPK3 and osteosarcoma: While most studies suggest that the inhibition of ERK 1/2 leads to increased apoptosis and decreased metastasis [24–26], some studies conclude that the activation of RAF/MAPK/MEK/ERK1/2 pathway is required for osteosarcoma cells apoptosis [27].